CencoraWBO:ABC -0.27%69 PB Ratio is 16.84 as of Jun. 27, 2026, which is 4% above its 10-year median of 16.13. GuruFocus rates WBO:ABC with a GF Score™ of 69/100 and a GF Value™ of €259.48 (Fairly Valued). The stock has 1 warning sign investors should review. Among 112 Medical Distribution companies, Cencora ranks worse than 97.32% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-27), Cencora's share price is €254.30. Cencora's Book Value per Share for the quarter that ended in Mar. 2026 was €15.11. Hence, Cencora's PB Ratio of today is 16.84.
Good Sign:
Cencora Inc stock PB Ratio (=16.38) is close to 5-year low of 14.76.
The historical rank and industry rank for Cencora's PB Ratio or its related term are showing as below:
WBO:ABC'
s PB Ratio Range Over the Past 10 Years
Min: 4.61 Med: 16.13 Max: 683.83
Current: 16.38
During the past 13 years, Cencora's highest PB Ratio was 683.83. The lowest was 4.61. And the median was 16.13.
WBO:ABC's PB Ratio is ranked worse than 97.32% of 112
companies
in the Medical Distribution industry
Industry Median: 1.03
vs WBO:ABC: 16.38
During the past 12 months, Cencora's average Book Value Per Share Growth Rate was 234.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Cencora was 171.10% per year. The lowest was -57.30% per year. And the median was 5.45% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Cencora PB Ratio Related Terms
Cencora PB Ratio Historical Data
* Premium members only.
The historical data trend for Cencora's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Cencora's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cencora PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cencora's PB Ratio distribution charts can be found below:
* The bar in red indicates where Cencora's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Cencora's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Cencora (WBO:ABC) has a PB Ratio of 16.84 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cencora and its competitors. This is near median its historical median of 16.13. Over the past decade, Cencora's PB Ratio has ranged from 4.61 to 683.83. According to the industry distribution chart, Cencora ranks #109 out of 112 companies in the Medical Distribution industry, placing it in the top 97.3%.
Is Cencora's PB Ratio too high?
Cencora's current PB Ratio of 16.84 is near median its 10-year median of 16.13. Over the past 10 years, this metric has ranged from a low of 4.61 to a high of 683.83. The Medical Distribution industry median PB Ratio is 1.03. Cencora's value of 16.84 is 1535% above this industry median. Based on the distribution chart, Cencora ranks #109 out of 112 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cencora has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's PB Ratio compare to CAH and MCK?
According to the Medical Distribution industry distribution chart, Cencora ranks #109 out of 112 companies for PB Ratio. This places Cencora in the lower half of its industry. The industry median PB Ratio is 1.03. Cencora's value of 16.84 is 1535% above this benchmark. Historically, Cencora's own PB Ratio has ranged from 4.61 to 683.83 over the past decade. While the company's 10-year median is 16.13 vs. the industry median of 1.03, Cencora has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.03, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cencora's current PB Ratio of 16.84 is 1535% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cencora and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cencora's current PB Ratio is 16.84, which is near median its own 10-year median of 16.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €259.48, compared to a current price of €254.30 — trading 2% below its estimated fair value. The current PB Ratio is 16.84, which is near median its 10-year median of 16.13 and 1535% above the Medical Distribution industry median of 1.03. Cencora's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Cencora (WBO:ABC), the current PB Ratio is 16.84 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cencora (WBO:ABC) Overvalued in 2026?
Based on GuruFocus' analysis, Cencora stock appears to be undervalued.
The current stock price of €254.30 is trading 2% below its estimated GF Value™ of €259.48.
GuruFocus considers Cencora to be Fairly Valued.
Key valuation signals for WBO:ABC:
PB Ratio: 16.84 (near median its 10-year median of 16.13)
GF Value™: €259.48 vs. price of €254.30 (2% below fair value)
Industry Position: 1535% above the Medical Distribution median (#109 of 112)
No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
69GF Score
Get the complete analysis for WBO:ABC
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ABC has been successfully added to your 
